-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EpWjMJqp9GsCsbsdZbMUGRq9sBZM8DH2ax5cANSU47wfWFlqrcHRbzCPLicm0Z9f qV97i01pIrzQaKUmBGqwPg== 0000910680-04-001097.txt : 20041019 0000910680-04-001097.hdr.sgml : 20041019 20041019170128 ACCESSION NUMBER: 0000910680-04-001097 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20041018 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20041019 DATE AS OF CHANGE: 20041019 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPHTHALMIC IMAGING SYSTEMS CENTRAL INDEX KEY: 0000885317 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 943035367 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11140 FILM NUMBER: 041085866 BUSINESS ADDRESS: STREET 1: 221 LATHROP WAY STREET 2: SUITE 1 CITY: SACRAMENTO STATE: CA ZIP: 95815 BUSINESS PHONE: 9166462020 MAIL ADDRESS: STREET 1: 221 LATHROP WAY STREET 2: SUITE 1 CITY: SACRAMENTO STATE: CA ZIP: 95815 FORMER COMPANY: FORMER CONFORMED NAME: OPHTHALMIC IMAGING SYSTEMS INC DATE OF NAME CHANGE: 19930328 8-K 1 f8k101804.txt CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 18, 2004 OPHTHALMIC IMAGING SYSTEMS (Exact Name of Registrant as Specified in its Charter) CALIFORNIA 1-11140 94-3035367 - -------------------------------------------------------------------------------- (State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer Incorporation) Identification No.) 221 Lathrop Way, Suite I Sacramento, California 95815 - -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) (Registrant's telephone number, including area code): (916) 646-2020 Not Applicable - -------------------------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01. Other Events. On October 18, 2004, the Company issued a press release, attached to this Current Report on Form 8-K (the "Report") as Exhibit 99.1, reporting that it will launch two new products at the first Joint Meeting of the American Academy of Ophthalmology (AAO) and the European Society of Ophthalmology (SOE) being held from October 23 to 26, 2004 in New Orleans, Louisiana. The information in this Report, including the exhibit, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. It shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing. Item 9.01. Financial Statements and Exhibits. (c) Exhibits: Exhibit Number Description 99.1 Press Release of the registrant dated October 18, 2004. -2- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 19, 2004 OPHTHALMIC IMAGING SYSTEMS By: /s/ Ariel Shenhar ------------------------ Name: Ariel Shenhar Title: Chief Financial Officer, Vice President, and Secretary EXHIBIT INDEX Exhibit Number Description - ------ ----------- 99.1 Press Release of the registrant dated October 18, 2004. EX-99 2 ex99_1-f8k101804.txt EX-99.1; PRESS RELEASE Exhibit 99.1 OPHTHALMIC IMAGING SYSTEMS CONTACTS: Gil Allon, CEO 221 Lathrop Way, Suite I Ariel Shenhar, CFO Sacramento, CA 95815 (916) 646-2020 INVESTOR RELATIONS Evan Smith, CFA / Erica Pettit KCSA Worldwide 212-896-1251 / 212-896-1248 FOR IMMEDIATE RELEASE OPHTHALMIC IMAGING SYSTEMS TO LAUNCH WINSTATION 3200(TM) AND W EBSTATION(TM) AT THE FIRST JOINT MEETING OF THE AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) AND THE EUROPEAN SOCIETY OF OPHTHALMOLOGY (SOE) - - - AAO and SOE Joint Meeting, New Orleans October 23 - 26 SACRAMENTO, California, October 18, 2004. Ophthalmic Imaging Systems (the "Company") (OTCBB:OISI), a leading provider of ophthalmic digital imaging and informatics solutions, announced today that it will launch two new products at the first Joint Meeting of the American Academy of Ophthalmology (AAO) and the European Society of Ophthalmology (SOE) being held from October 23 to 26, 2004 in New Orleans, LA. Gil Allon, CEO of Ophthalmic Imaging Systems, commented, "The AAO conference is the most important commercial exhibition for us because many key decision-makers attend it to learn more about new innovations and trends in the ophthalmic industry. Launching OIS WinStation 3200(TM) and OIS WebStation(TM) will be our focus at the AAO and will provide additional attraction to our exhibit this year." OIS WinStation 3200 is an exciting new model of imaging system that offers substantially greater performance at a very attractive cost. The value propostion of WinStation 3200 far exceeds that of any other product on the market today. The new OIS WebStation offers on-line image and data storage and provides secure remote access for viewing ophthalmic images, a variety of tests, and reports. It is compatible with OIS imaging and EMR solutions, and offers unparalleled ease of operation and workflow efficiency. WebStation is the final element of OIS' Ophthalmology Office(TM) solution, which offers seamless integration of digital imaging, EMR and practice management. The Company will exhibit at the first Joint Meeting of the American Academy of Ophthalmology (AAO) and the European Society of Ophthalmology (SOE) taking place at the New Orleans convention center from October 23 - 26, 2004 [Booth # 943]. Ophthalmic Imaging Systems, a majority-owned subsidiary of MediVision, is the leading provider of ophthalmic digital imaging systems. The Company designs, develops, manufactures and markets digital imaging systems and informatics solutions for the eye care market. With over nineteen years in the ophthalmic imaging business, the Company has consistently introduced new, innovative technology. The Company, together with MediVision, co-market and support their products worldwide through an extensive network of dealers, distributors, and direct representatives. STATEMENTS IN THIS PRESS RELEASE WHICH ARE NOT HISTORICAL DATA ARE FORWARD-LOOKING STATEMENTS WHICH INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES OR OTHER FACTORS NOT UNDER THE COMPANY'S CONTROL, WHICH MAY CAUSE ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS OF THE COMPANY TO BE MATERIALLY DIFFERENT FROM THE RESULTS, PERFORMANCE OR OTHER EXPECTATIONS IMPLIED BY THESE FORWARD-LOOKING STATEMENTS. THESE FACTORS INCLUDE, BUT ARE NOT LIMITED TO, THOSE DETAILED IN THE COMPANY'S PERIODIC FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION. -----END PRIVACY-ENHANCED MESSAGE-----